Definitive Contract HHSN272201700012C
Award Date
2/28/17
Potential Completion Date
2/28/23
Potential Value
$7.9M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Chromologic LLC
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Monrovia, CA 91016, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
29
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $4,879,349 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Chromologic LLC, a minority-owned small business located in Monrovia, California. The contract is for the research and development of biodosimetry approaches and medical countermeasures to assess and mitigate acute or delayed radiation injuries. This work supports NIAID's goals of developing safe and effective countermeasures to reduce radiation-associated mortality...
This federal contract award, valued at $299,914.00, was granted to Chromologic LLC, a minority-owned, for-profit limited liability company, by the National Institute of Allergy and Infectious Diseases, a civilian agency. The contract, which is a Definitive Contract with a Firm Fixed Price pricing type, is for the SBIR 134 - CHROMOLOGIC project. The contract does not have a set-aside designation and has an ultimate completion date of September 24, 2025. Chromologic is a manufacturer of goods that...
This is a firm-fixed-price Definitive Contract awarded by the U.S. Army Medical Command (MEDCOM) to Chromologic LLC, a minority-owned small business located in Monrovia, California. The contract, valued at $1,099,884.66, is for Chromologic's Phase II SBIR (Small Business Innovation Research) effort on "Radioprotection by JP4-039-MLV Nanoparticle Drugs." The contract is a total small business set-aside and has an ultimate completion date of December 28, 2024. Chromologic is a...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract, valued at $224,997.00, was awarded to Chromologic LLC, a minority-owned, for-profit limited liability company, to conduct research and development for the BICER program. The contract has a Firm Fixed Price pricing type and a completion date of September 9, 2016....
This is a U.S. government contract awarded to Chromologic LLC, a minority-owned, for-profit limited liability company, for a Small Business Innovation Research (SBIR) Phase I project. The contract, valued at $167,497.00, is a firm fixed-price purchase order set aside for small businesses. The contract supports research and development activities in areas such as medical devices, pharmaceuticals, diagnostics, and countermeasures, leveraging Chromologic's expertise in biomedical engineering,...
This is a Small Business Innovation Research (SBIR) Phase II contract award to Chromologic LLC, a minority-owned, for-profit limited liability company. The $1,699,887.38 fixed-price level of effort contract was awarded by the Defense Microelectronics Activity (DMEA), a U.S. Department of Defense agency, and is designated as a total small business set-aside. The contract involves research and development of innovative technologies for the SBIR program, including work on portable oxygen generation...
This is a $999,978.12 Cost Plus Fixed Fee contract awarded by the Defense Health Agency (DHA) to Chromologic LLC, a minority-owned, for-profit limited liability company. The contract is for a DHP SBIR PHASE II #A2-5822 research project under the SBIR Program Phase II Action and has a total small business set-aside designation. The contract supports Chromologic's ongoing research and development efforts in areas such as medical devices, pharmaceuticals, diagnostics, and countermeasures....
This federal contract award to Chromologic LLC, a minority-owned small business, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) for the "Development of Second-Generation Probiotics as Radiation Mitigators." The $2,709,458.08 cost-plus-fixed-fee contract has a 5-year period of performance through March 2026. The contract supports research and development of advanced therapeutic approaches, including...
This is a $399,975.00 Phase I Small Business Innovation Research (SBIR) contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Chromologic LLC, a minority-owned small business. The contract is for the development of an "Organ-on-VascularNet Model for In Vitro Evaluation of Radiation and Drug Therapies." This research supports NCI's mission to address critical needs in cancer treatment and prevention. The contract has a firm...
This contract is a Small Business Innovation Research (SBIR) Phase II award to Chromologic LLC, a minority-owned, for-profit limited liability company. The $1,099,984.00 cost-plus-fixed-fee contract was awarded by the Naval Air Warfare Center for research and development of innovative technologies. As a total small business set-aside, this award supports Chromologic's expertise in areas such as medical devices, pharmaceuticals, diagnostics, and countermeasures. The company has a strong track...